Chang Suk Suh
Overview
Explore the profile of Chang Suk Suh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
201
Citations
1784
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Han J, Kim H, Hong Y, Chang J, Kim S, Ku S, et al.
Eur J Obstet Gynecol Reprod Biol
. 2025 Mar;
308:195-200.
PMID: 40081024
Objective: To evaluate how volumetric percent density (VPD) changes longitudinally with postmenopausal hormone therapy (HT). Study Design: Medical records of 297 women who visited the outpatient clinic in a tertiary...
2.
Han S, Kim H, Hong Y, Kim S, Ku S, Suh C
J Obstet Gynaecol
. 2024 Dec;
45(1):2436518.
PMID: 39660723
Background: Luteal phase support (LPS) with progesterone is a generally accepted practice after controlled ovarian stimulation, although the best protocols for LPS have been debated. We aimed to compare the...
3.
Hong Y, Paik H, Kim S, Lee J, Suh C
J Surg Case Rep
. 2024 Mar;
2024(3):rjae189.
PMID: 38549718
Trocar site hernia is a rare, serious operation-related complication after robotic gynecologic surgery. Here, we present two 8-mm port-site hernia cases after three-port robotic myomectomy with a review of reported...
4.
Paik H, Hong Y, Choi Y, Kim S, Lee J, Suh C
J Clin Med
. 2024 Mar;
13(6).
PMID: 38542030
Reduced-port robotic myomectomy (RPRM) using Da Vinci Xi™ is a good fertility-saving surgical option, but the surgical and fertility outcomes are unknown. This was a retrospective cohort study evaluating the...
5.
Han S, Kim H, Ku S, Suh C
Gynecol Endocrinol
. 2024 Feb;
40(1):2309349.
PMID: 38306179
Objective: Both oral contraceptive pills (OCPs) and cyclic medroxyprogesterone acetate (MPA) are widely used to control menstrual abnormalities in women with polycystic ovary syndrome (PCOS). We aimed to evaluate the...
6.
Choi Y, Hong Y, Paik H, Kim S, Lee J, Suh C
J Korean Med Sci
. 2024 Jan;
39(1):e14.
PMID: 38193330
This article reports the live birth of a healthy newborn using vitrified-warmed oocytes from fertility preservation before ovarian surgery. The patient in our case underwent two cycles of controlled ovarian...
7.
Kim S, Won K, Hong Y, Kim S, Lee J, Jee B, et al.
Yonsei Med J
. 2022 Sep;
63(10):941-947.
PMID: 36168247
Purpose: The present study aimed to identify microorganisms in follicular fluids and to investigate their association with in vitro fertilization (IVF) outcomes. Materials And Methods: This study was conducted as...
8.
Han S, Kim H, Hong Y, Kim S, Ku S, Suh C
J Obstet Gynaecol Res
. 2022 May;
48(7):1795-1805.
PMID: 35603765
Aim: There is no validated tool to predict persistent ovulatory dysfunction after medication with oral contraceptives in women with polycystic ovary syndrome (PCOS), which is the most severe subtype of...
9.
Choi Y, Hong Y, Kim S, Kim S, Lee J, Suh C
Front Endocrinol (Lausanne)
. 2022 May;
13:845051.
PMID: 35518927
Objective: Oocyte (OC), embryo (EC), and ovarian tissue cryopreservation (OTC) are options for fertility preservation (FP) before going through gonadotoxic cancer treatment, or anticipated fertility decline in benign ovarian diseases,...
10.
Hong Y, Kim S, Lee J, Jee B, Suh C
Reprod Med Biol
. 2022 Apr;
21(1):e12440.
PMID: 35386366
Purpose: To determine the optimal maturation method to increase the yield of mature oocytes, especially for cancer patients with fewer chances of fertility preservation (FP) before gonadotoxic therapy. Methods: A...